The development of a blend-sampling technique to assess the uniformity of a powder mixture

被引:11
作者
Garcia, TP
Wilkinson, SJ
Scott, JF
机构
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Glaxo Wellcome Ltd, New Prod Intro Pharmaceut Technol, Dartford DA1 5AH, Kent, England
关键词
blend sampling; content uniformity; sampling bias; static charge;
D O I
10.1081/DDC-100103729
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This article discusses the challenges overcome during the development of a blend-sampling technique and the successful validation of the blending operation for a tablet dosage form containing 2% active ingredient. Content uniformity results are discussed for three pilot-scale (15-kg) and seven commercial-scale (150-kg) batches of tablets. Blend and core content uniformity data from the pilot-scale batches were acceptable. For the initial commercial-scale batches, although the tablet core content uniformity data were acceptable, the blend uniformity results were poor. The blend data for these batches had very high mean values, but acceptable relative standard deviations (RSDs). This suggested that the drug was being preferentially sampled by the thief but in a consistent, reproducible manner. Extensive testing was performed on a commercial-scale development batch to identify potential causes of sampling error. The results of this testing helped define the blend-sampling technique and strategy used to validate the mixing operation.
引用
收藏
页码:297 / 307
页数:11
相关论文
共 15 条
[1]   Unit dose sampling: A tale of two thieves [J].
Berman, J ;
Schoeneman, A ;
Shelton, JT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (11) :1121-1132
[2]   BLEND UNIFORMITY AND UNIT DOSE SAMPLING [J].
BERMAN, J ;
PLANCHARD, JA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (11) :1257-1283
[3]   Blending validation and content uniformity of low-content, noncohesive powder blends [J].
Carstensen, JT ;
Dali, MV .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (04) :285-290
[4]   SAMPLING IN BLENDING VALIDATION [J].
CARSTENSEN, JT ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (20) :2699-2708
[5]   EXAMINATION OF COMPONENTS OF VARIANCE FOR A PRODUCTION SCALE, LOW-DOSE POWDER BLEND AND RESULTING TABLETS [J].
GARCIA, T ;
ELSHEIMER, B ;
TARCZYNSKI, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (18) :2035-2045
[6]  
Garcia T P, 1998, Pharm Dev Technol, V3, P7, DOI 10.3109/10837459809028474
[7]  
HARWOOD CF, 1973, ACS DIV ORG COATINGS, V33, P508
[8]  
HARWOOD CF, 1977, J POWDER BULK SOLIDS, V11, P20
[9]  
LANTZ RL, 1989, PHARM DOSAGE FORMS T, V2, P27
[10]  
MOHAN S, 1997, PHARM TECHNOL APR, P116